Johane M. Robitaille

Johane M. Robitaille

Auto-generated profile, based on publicly available information

Johane M. Robitaille

Departments of Ophthalmology and Visual Sciences, Pathology and Pediatrics, Dalhousie University, Department of Surgery, IWK Health Centre, Halifax, Nova Scotia, Canada

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
JRJohane M. Robitaille
Johane M. Robitaille
RGRoxanne M. Gillett
Roxanne M. Gillett
MLMarissa A. LeBlanc
Marissa A. LeBlanc
DGDaniel Gaston
Daniel Gaston
MNMathew Nightingale
Mathew Nightingale
KBKaren Bedard
Karen Bedard
Microcephaly, lymphedema, and chorioretinal dysplasia (MLCRD), as well as chorioretinal dysplasia, microcephaly, and mental retardation (CDMMR), were recently reported by Ostergaard et al1 to result from mutations in the KIF11 gene (NCBI NM_004523), demonstrating that these conditions are allelic (OMIM 152950) with highly variable phenotypic expression. None of the patients with KIF11 mutations in that study had retinal folds or microphthalmia. Of the 27 mutation carriers identified, unilateral total retinal detachment was present in only 1 individual.

21 November 2010 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
JRJohane M Robitaille
Johane M Robitaille
BZBinyou Zheng
Binyou Zheng
KWKarin Wallace
Karin Wallace
MBM Jill Beis
M Jill Beis
CTCuneyt Tatlidil
Cuneyt Tatlidil
DGDuane L Guernsey
Duane L Guernsey
Aim The aim of this study is to assess the role of Frizzled-4 (FZD4) in familial exudative vitreoretinopathy (FEVR) and Coats disease. Methods Tissue samples were collected for DNA extraction and automated DNA sequencing of the two coding exons of FZD4 in both directions. Cases carrying a FZD4 mutation and demonstrating extreme disease severity were selected for direct automated sequencing of all coding exons of LRP5, NDP and TSPAN12. Clinical data were obtained for the purpose of identifying genotype–phenotype correlations. Results 68 probands were diagnosed as having autosomal dominant or sporadic FEVR. Eleven FZD4 mutations (five missense, three deletions, one insertion, two nonsense) were identified. Six of these mutations are novel, and none were found in 346 control chromosomes. In 16 cases of Coats disease, one polymorphism combination was found in two samples: no mutations were detected. No genotype–phenotype correlation emerged. Three severely affected cases with FZD4 mutations failed to show additional mutations in the three other FEVR genes. Conclusion The authors identified 12 FEVR probands with FZD4 mutations. FZD4 mutation screening can be a useful tool especially in mild or atypical cases of FEVR. Germ-line mutations in FZD4 do not appear to be a common cause of Coats disease.

11 August 2022 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
SESarah R. van der Ende
Sarah R. van der Ende
BMBenjamin S. Meyers
Benjamin S. Meyers
JCJenina E. Capasso
Jenina E. Capasso
MSMario Sasongko
Mario Sasongko
YYYoshihiro Yonekawa
Yoshihiro Yonekawa
JRJohane M. Robitaille
Johane M. Robitaille
Importance: Familial exudative vitreoretinopathy (FEVR) is a nonsyndromic autosomal dominant retinal disorder commonly caused by variants in the FZD4 gene. This study investigates the potential role beyond ocular abnormalities for FZD4 gene variants in patients with FEVR.Objective: To evaluate the role of FZD4 in symptoms beyond those associated with FEVR through a patient with biallelic variants in FZD4.Design, Setting, and Participants: This case series included the DNA testing and phenotyping of 1 patient proband and her parents, combined with signaling assays, to determine the association of patient-derived compound heterozygous variants on FZD4 signaling and biologic function.Main Outcomes and Measures: FZD4 genes were tested using next-generation sequencing and Sanger sequencing. Cell-based assays measured the effect of the variants on FZD4 signaling.Results: The proband presented with absent red reflexes from complete tractional retinal detachments diagnosed at 3 days of age and failed the newborn screening hearing test. Auditory brainstem response at 6 months of age showed bilateral mild to moderate high-frequency sensorineural hearing loss. The patient manifested developmental delays in speech and walking. Intravenous fluorescein angiography (IVFA) of the patient’s parents detected stage 1 FEVR. Genetic testing revealed 2 FZD4 variants in the patient, each variant found in 1 parent. Signaling assays confirmed that the presence of both variants was associated with significantly worse signaling activity compared with the heterozygous state.Conclusions and Relevance: Results of this case series suggest that extraocular syndromic FEVR was associated with FZD4 variants. The decrease in FZD4 signaling owing to the biallelic nature of the disease resulted in hearing deficits, developmental delays, and a more severe retinal phenotype.

4 August 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MNMichael H. Ngo
Michael H. Ngo
JBJoanna Borowska-Fielding
Joanna Borowska-Fielding
GHGodfrey Heathcote
Godfrey Heathcote
SNSara Nejat
Sara Nejat
MKMelanie E. Kelly
Melanie E. Kelly
JRJohane M. Robitaille
Johane M. Robitaille
Mutations in genes that code for components of the Norrin-FZD4 ligand-receptor complex cause the inherited childhood blinding disorder familial exudative vitreoretinopathy (FEVR). Statistical evidence from studies of patients at risk for the acquired disease retinopathy of prematurity (ROP) suggest that rare polymorphisms in these same genes increase the risk of developing severe ROP, implying that decreased Norrin-FZD4 activity predisposes patients to more severe ROP. To test this hypothesis, we measured the development and recovery of retinopathy in wild type and Fzd4 heterozygous mice in the absence or presence of ocular ischemic retinopathy (OIR) treatment. Avascular and total retinal vascular areas and patterning were determined, and vessel number and caliber were quantified. In room air, there was a small delay in retinal vascularization in Fzd4 heterozygous mice that resolved as mice reached maturity suggestive of a slight defect in retinal vascular development. Subsequent to OIR treatment there was no difference between wild type and Fzd4 heterozygous mice in the vaso-obliterated area following exposure to high oxygen. Importantly, after return of Fzd4 heterozygous mice to room air subsequent to OIR treatment, there was a substantial delay in retinal revascularization of the avascular area surrounding the optic nerve, as well as delayed vascularization toward the periphery of the retina. Our study demonstrates that a small decrease in Norrin-Fzd4 dependent retinal vascular development lengthens the period during which complications from OIR could occur.

9 January 2022 in Children
Verified
Journal Article
Open access
PDF file
DFDavid Forner
David Forner
PLPatricia K. Leslie
Patricia K. Leslie
AAAbdullah Aldaihani
Abdullah Aldaihani
MBMichael Bezuhly
Michael Bezuhly
CNChristopher W. Noel
Christopher W. Noel
PHPaul Hong
Paul Hong
Due to resource restrictions related to the COVID-19 pandemic, many pediatric patients are facing substantial delays for surgery, potentially resulting in additional distress for caregivers. We aimed to assess the experiences and psychosocial distress of parents during COVID-19 as they relate to the pandemic, waiting for surgery, and the combined effects of both events. The was a cross-sectional qualitative study. Parents with children who faced treatment delays during the initial wave of the COVID-19 pandemic for elective, non-emergent procedures across a variety of surgical specialties were recruited. Semi-structured telephone interviews and thematic analysis were utilized. Thematic saturation was reached with eighteen participants. Four themes were identified: coping with COVID-19, distress levels, quality and nature of communication with the surgical team, and the experience of COVID-19 related hospital restrictions. Participants reported varying levels of distress due to the delay in surgery, such as the fear of developmental delay or disease progression for their child. They also indicated their own physical and mental health had been impacted by emotional distress related to both COVID-19 and delays in treatment. Most participants experienced the COVID-19-related hospital restrictions as distressing. This related predominantly to limiting in-hospital caregivers to only one caregiver. Participants were found to have substantial levels of psychosocial distress. Targeted social and emotional support may be helpful in reducing parental distress as the pandemic timeframe continues. Within the limits of individual health systems, reducing restrictions to the number of allowed care givers may help allay distress felt by parents.

3 February 2025 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
SESarah van der Ende
Sarah van der Ende
KBKaren Bedard
Karen Bedard
KWKarin Wallace
Karin Wallace
MMMichael P. Mackley
Michael P. Mackley
MNMathew Nightingale
Mathew Nightingale
OCon behalf of The FEVR Consortium
on behalf of The FEVR Consortium
To investigate the gene variant spectrum in patients with familial exudative vitreoretinopathy (FEVR). Probands clinically diagnosed with FEVR and their relatives were enrolled and clinical information and DNA collected. An expanded FEVR panel was used, including six recognized FEVR genes (FZD4, NDP, LRP5, TSPAN12, ZNF408, and CTNNB1) and 19 genes previously associated with ocular features overlapping FEVR (FEVR-associated genes). Variants identified using targeted next-generation sequencing and/or Sanger sequencing were analyzed and classified using the American College of Medical Genetics and Clinical Genome Resource Sequence Variant Interpretation (ClinGen SVI) working group recommendations to detect disease-causing variants (DCVs). Analyses of data from a cohort of 94 probands provided a molecular diagnosis for 39 (41.5%) probands: 34 (87.2%) had a single DCV, whereas 5 (12.8%) harbored more than 1 DCV. Of 41 total DCVs in solved probands, 33 (80.5%) were in 4 of the 6 recognized genes, LRP5, FZD4, TSPAN12, and NDP, whereas 8 were found in FEVR-associated genes, 6 in KIF11, and 2 (LAMA1 and DOCK6) each in association with a KIF11 DCV. Reanalyzing variants using the latest criteria impacted the variant classification in five probands (5.3%), changing variants that were once deemed likely pathogenic to variants of uncertain significance. The expanded FEVR gene panel detected DCVs in nearly one-half of our cohort. Including the criteria used in classification will improve transparency of variant calls as more data become available. Four FEVR genes account for most cases, and the role of rare FEVR genes and candidate genes requires further study.